Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis
Perifosine Increases PFS In Phase II Study
Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time
Carfilzomib Demonstrates Clinical Benefit Rate of 64%
Single-Letter Mutation Found Responsible For Waldenstrom’s
New Methods Uncover 1,800 RNAs Linked To Breast Cancer
Gene Expression Analyses Can Guide MDS Treatments
Analysis Reveals Patient Subset With Lower PFS in Phase III Trial
Interim Results Show Vaccine Lowers Breast Cancer Recurrence
CTCs Do Not Affect Survival, But Could Signal Metastases
Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects
Trials Approved by NCI CTEP For the Month of December
FDA Grants Orphan Designation To Photofrin for Mesothelioma
Trending Stories
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - What NHS-Galleri taught us—and what it didn’t
- Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
